CLSI MM07-A2 (R2018)
Fluorescence In Situ Hybridization Methods for Clinical Laboratories; Approved Guideline--Second Edition, MM07A2Estandard by Clinical and Laboratory Standards Institute, 08/30/2013
BS PIP AWS SAIA AWPA ASSE
CLSI
Fluorescence In Situ Hybridization Methods for Clinical Laboratories; Approved Guideline--Second Edition, MM07A2Estandard by Clinical and Laboratory Standards Institute, 08/30/2013
Establishing Molecular Testing in Clinical Laboratory Environments; Proposed Guideline, MM19AEstandard by Clinical and Laboratory Standards Institute, 11/01/2011
IT Security of In Vitro Diagnostic Instruments and Software Systems; Proposed Standard, AUTO11A2Estandard by Clinical and Laboratory Standards Institute, 10/01/2014
Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1Estandard by Clinical and Laboratory Standards Institute, 03/01/2017
Laboratory Detection and Identification of Mycobacteria; Approved Guideline, M48AEstandard by Clinical and Laboratory Standards Institute, 01/01/2008
Procedures for the Erythrocyte Sedimentation Rate Test; Approved Standard - Fifth Edition, H02A5standard by Clinical and Laboratory Standards Institute, 05/01/2011
Essential Tools for Implementation and Management of a Point-of-Care Testing Program, POCT04Ed3Estandard by Clinical and Laboratory Standards Institute, 06/01/2016
Newborn Screening for Cystic Fibrosis; Approved Guideline (Formerly I/LA35-A), NBS05AEstandard by Clinical and Laboratory Standards Institute,
Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline (formerly I/LA31-A), NBS03AEstandard by Clinical and Laboratory Standards Institute,
Methods for Broth Dilution Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Approved Guideline, VET04AE, Performance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Second Informational Supplement,…